Literature DB >> 28430891

Development and Validation of Diagnostic Criteria for IBD Subtypes Including IBD-unclassified in Children: a Multicentre Study From the Pediatric IBD Porto Group of ESPGHAN.

Liron Birimberg-Schwartz1, David M Zucker2, Amichay Akriv2, Salvatore Cucchiara3, Fiona L Cameron4, David C Wilson4, Iza Lazowska5, Lambri Yianni6, Siba Prosad Paul7, Claudio Romano8, Sanja Kolacek9, Stephan Buderus10, Anders Pærregaard11, Richard K Russell12, Johanna C Escher13, Dan Turner1,2.   

Abstract

BACKGROUND: The revised Porto criteria identify subtypes of paediatric inflammatory bowel diseases: ulcerative colitis [UC], atypical UC, inflammatory bowel disease unclassified [IBDU], and Crohn's disease [CD]. Others have proposed another subclassifiction of Crohn's colitis. In continuation of the Porto criteria, we aimed to derive and validate criteria, termed "PIBD-classes," for standardising the classification of the different IBD subtypes.
METHODS: This was a multicentre retrospective longitudinal study from 23 centres affiliated with the Port -group of ESPGHAN. Both a hypothesis-driven judgmental approach and mathematical classification and regression tree [CART] modelling were used for creating a diagnostic algorithm. Since small bowel inflammation is easily recognised as CD, we focused here primarily on the phenotype of colitis.
RESULTS: In all, 749 IBD children were enrolled: 236 [32%] Crohn's colitis, 272 [36%] UC and 241 [32%] IBDU [age 10.9 ± 3.6 years] with a median follow-up of 2.8 years (interquartile range [IQR] 1.7-4.3). A total of 23 features were clustered in three classes according to their prevalence in UC: six class-1 features [0% prevalence in UC], 12 class-2 features [< 5% prevalence], and five class-3 features [5-10% prevalence]. According to the algorithm, the disease should be classified as UC if no features exist in any of the classes. When at least one feature exists, different combinations classify the disease into atypical UC, IBDU or CD. The algorithm differentiated UC from CD and IBDU with 80% sensitivity (95% confidence interval [CI] 71-88%) and 84% specificity [77-89%], and CD from IBDU and UC with 78% sensitivity [67-87%] and 94% specificity [89-97%].
CONCLUSIONS: The validated PIBD-classes algorithm can adequately classify children with IBD into small bowel CD, colonic CD, IBDU, atypical UC, and UC.
Copyright © 2017 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  Crohn’s colitis; Crohn’s disease; IBD-unclassified; UC; classification; pediatric

Mesh:

Year:  2017        PMID: 28430891     DOI: 10.1093/ecco-jcc/jjx053

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   10.020


  18 in total

1.  Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study.

Authors:  Mohamed Attauabi; Gorm Roager Madsen; Flemming Bendtsen; Anne Vibeke Wewer; Rune Wilkens; Johan Ilvemark; Nora Vladimirova; Annette Bøjer Jensen; Frank Krieger Jensen; Sanja Bay Hansen; Hartwig Roman Siebner; Yousef Jesper Wirenfeldt Nielsen; Jakob M Møller; Henrik S Thomsen; Simon Francis Thomsen; Helene Andrea Sinclair Ingels; Klaus Theede; Trine Boysen; Jacob T Bjerrum; Christian Jakobsen; Maria Dorn-Rasmussen; Sabine Jansson; Yiqiu Yao; Ewa Anna Burian; Frederik Trier Møller; Viktoria Fana; Charlotte Wiell; Lene Terslev; Mikkel Østergaard; Kristina Bertl; Andreas Stavropoulos; Jakob B Seidelin; Johan Burisch
Journal:  BMJ Open       Date:  2022-06-27       Impact factor: 3.006

2.  Learning Longitudinal Patterns and Subtypes of Pediatric Crohn Disease Treated With Infliximab via Trajectory Cluster Analysis.

Authors:  Andrew Chen; Ronen Stein; Robert N Baldassano; Jing Huang
Journal:  J Pediatr Gastroenterol Nutr       Date:  2022-03-01       Impact factor: 3.288

3.  Granulomatous Upper Gastrointestinal Inflammation in Pediatric Ulcerative Colitis.

Authors:  Karen Queliza; Faith D Ihekweazu; Deborah Schady; Craig Jensen; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-04       Impact factor: 2.839

Review 4.  An Overview of Inflammatory Bowel Disease Unclassified in Children.

Authors:  Lauren E Thurgate; Daniel A Lemberg; Andrew S Day; Steven T Leach
Journal:  Inflamm Intest Dis       Date:  2019-07-19

Review 5.  Very Early Onset-IBD: evidence for the need of a multidisciplinary approach.

Authors:  Paola Parente; Maria Pastore; Federica Grillo; Matteo Fassan; Paola Francalanci; Angelica Dirodi; Chiara Rossi; Giovanni Arpa; Paola De Angelis; Irene Gullo; Luca Mastracci; Rita Alaggio; Alessandro Vanoli
Journal:  Pathologica       Date:  2021-12-02

6.  Illness Perceptions and Depression Are Associated with Health-Related Quality of Life in Youth with Inflammatory Bowel Disease.

Authors:  Luuk Stapersma; Gertrude van den Brink; Jan van der Ende; Alexander G Bodelier; Herbert M van Wering; Pamela C W M Hurkmans; M Luisa Mearin; Andrea E van der Meulen-de Jong; Johanna C Escher; Elisabeth M W J Utens
Journal:  Int J Behav Med       Date:  2019-08

7.  Korean Children and Adolescents with Crohn's Disease Are More Likely to Present with Perianal Fistulizing Disease at Diagnosis Compared to Their European Counterparts.

Authors:  Ben Kang; Jung Eun Kim; Jae Hun Jung; Jae Young Choe; Mi Jin Kim; Yon Ho Choe; Seung Kim; Hong Koh; Yoo Min Lee; Jee Hyun Lee; Yoon Lee; Ji-Hyuk Lee; Hae Jeong Lee; Hyo-Jeong Jang; Youjin Choi; So Yoon Choi; Ju Young Kim; Byung-Ho Choe
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2020-01-09

8.  Simultaneous Assessment of Urinary and Fecal Volatile Organic Compound Analysis in De Novo Pediatric IBD.

Authors:  Sofia El Manouni El Hassani; Sofie Bosch; Jesse P M Lemmen; Marina Brizzio Brentar; Ibrahim Ayada; Alfian N Wicaksono; James A Covington; Marc A Benninga; Nanne K H de Boer; Tim G J de Meij
Journal:  Sensors (Basel)       Date:  2019-10-16       Impact factor: 3.576

Review 9.  MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer.

Authors:  Jaslin P James; Lene Buhl Riis; Mikkel Malham; Estrid Høgdall; Ebbe Langholz; Boye S Nielsen
Journal:  Int J Mol Sci       Date:  2020-10-24       Impact factor: 5.923

10.  Features and Outcomes of Children with Ulcerative Colitis who Undergo a Diagnostic Change: A Single-Center Experience.

Authors:  Natsuki Ito; Ichiro Takeuchi; Reiko Kyodo; Yuri Hirano; Takuro Sato; Masaaki Usami; Hirotaka Shimizu; Toshiaki Shimizu; Katsuhiro Arai
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.